Anti-B3GALT4 antibodies are used in the immunodetection of the protein beta-1,3-galactosyltransferase 4. In humans, the canonical protein has a reported length of 378 amino acid residues and a mass of 41.5 kDa. Its subcellular localization is in the Golgi. It is reported to be highly expressed in the heart, skeletal muscle and pancreas and, to a lesser extent, in the brain, placenta, kidney, liver and lung. A member of the Glycosyltransferase 31 protein family, B3GALT4 is known to be involved in GM1/GD1B/GA1 ganglioside biosynthesis. Synonyms for this target antigen include GALT2, GALT4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, and BETA3GALT4. B3GALT4 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish and chimpanzee species. Some B3GALT4 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.